Moloboco, Baby Boy .
HRN: 25-84-58 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2024
AMPICILLIN 250MG (VIAL)
09/13/2024
09/19/2024
IV
175mg
Q12H
PSNB (PROMX25hrs)
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes